Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

05 févr. 2022 09h54 HE | Source: Hagens Berman Sobol Shapiro LLP

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Revance Therapeutics (RVNC) Investors to Lead Plaintiff Opportunity in Securities Fraud Action

SAN FRANCISCO, Feb. 05, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Revance Therapeutics, Inc. (NASDAQ: RVNC) investors to with significant losses to submit your losses now. Class Period: Nov. 25,...
31 janv. 2022 13h26 HE | Source: Hagens Berman Sobol Shapiro LLP

RVNC 8-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Revance Therapeutics (RVNC) Investors with Significant Losses to Contact Firm’s Attorneys, Securities Class Action Pending

SAN FRANCISCO, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Revance Therapeutics, Inc. (NASDAQ: RVNC) investors to with significant losses to submit your losses now. Class Period: Nov. 25,...
24 janv. 2022 09h37 HE | Source: Hagens Berman Sobol Shapiro LLP

RVNC DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Revance Therapeutics (RVNC) Investors with Significant Losses to Contact Firm’s Attorneys, Securities Class Action Pending

SAN FRANCISCO, Jan. 24, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Revance Therapeutics, Inc. (NASDAQ: RVNC) investors to with significant losses to submit your losses now. Class Period: Nov. 25,...
18 janv. 2022 14h11 HE | Source: Hagens Berman Sobol Shapiro LLP

RVNC INVESTOR ALERT: Hagens Berman, National Trial Attorneys, Encourages Revance Therapeutics (RVNC) Investors with Significant Losses to Contact Firm’s Attorneys, Securities Class Action Filed

SAN FRANCISCO, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Revance Therapeutics, Inc. (NASDAQ: RVNC) investors to with significant losses to submit your losses now. Class Period: Nov. 25,...
13 janv. 2022 14h57 HE | Source: Hagens Berman Sobol Shapiro LLP

RVNC DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Revance Therapeutics (RVNC) Investors with Significant Losses to Contact Firm’s Attorneys, Securities Class Action Pending

SAN FRANCISCO, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Revance Therapeutics, Inc. (NASDAQ: RVNC) investors to with significant losses to submit your losses now. Class Period: Nov. 25,...
08 janv. 2022 13h10 HE | Source: Hagens Berman Sobol Shapiro LLP

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Revance Therapeutics (RVNC) Investors to Contact Firm’s Attorneys, Deadline Approaching in Securities Class Action

SAN FRANCISCO, Jan. 08, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Revance Therapeutics, Inc. (NASDAQ: RVNC) investors to with significant losses to submit your losses now. Class Period: Nov....
03 janv. 2022 14h30 HE | Source: Hagens Berman Sobol Shapiro LLP

RVNC FRAUD ALERT: Hagens Berman Encourages Revance Therapeutics (RVNC) Investors with Significant Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Pending

SAN FRANCISCO, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Revance Therapeutics, Inc. (NASDAQ: RVNC) investors to with significant losses to submit your losses now. Class Period: Nov. 25,...
28 déc. 2021 09h57 HE | Source: Hagens Berman Sobol Shapiro LLP

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Revance Therapeutics (RVNC) Investors with Significant Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Filed

SAN FRANCISCO, Dec. 28, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Revance Therapeutics, Inc. (NASDAQ: RVNC) investors to with significant losses to submit your losses now. Class Period: Nov. 25,...
23 déc. 2021 10h12 HE | Source: Hagens Berman Sobol Shapiro LLP

RVNC INVESTOR FRAUD: Hagens Berman, National Trial Attorneys, Encourages Revance Therapeutics (RVNC) Investors with Significant Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Filed

SAN FRANCISCO, Dec. 23, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Revance Therapeutics, Inc. (NASDAQ: RVNC) investors to with significant losses to submit your losses now. Class Period:Nov. 25,...
18 déc. 2021 10h11 HE | Source: Hagens Berman Sobol Shapiro LLP

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Revance Therapeutics (RVNC) Investors with Significant Losses to Contact Firm’s Attorneys, Lead Plaintiff Opportunity in Securities Fraud Class Action

SAN FRANCISCO, Dec. 18, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Revance Therapeutics, Inc. (NASDAQ: RVNC) investors to with significant losses to submit your losses now. Class Period: Nov. 25,...

Page suivante